Peter Piot and colleagues' list of lessons learnt and myths dispelled in the AIDS response 1 is by no means exhaustive. Another myth is that myths about HIV will disappear on their own; as a result, not much eff ort is expended in fi ghting them. Consequently, the myths become ingrained and gain credibility. A related lesson learnt is that national policy makers are tired of researchers telling them what the problem is. They also need information on what should be done. During the early years of the AIDS pandemic, policy makers and scientists often seemed to exist in two diff erent worlds. However, with improved communication (through opportunities such as the UN General Assembly Special Session on AIDS) came the convergence of money, politics, and science.
There is potential for international funding agencies to strengthen this researcher-policy maker collaboration. One possibility could be the extension of current investments in health systems of low-income countries 1 to advocacy for evidence-informed policy making. Policy makers in these countries need access to robust evidence about eff ective services as well as governance and fi nancial arrangements for their cost-eff ective delivery. [2] [3] [4] Strengthening the use of research evidence and the ability of policy makers to make appropriate judgments about its relevance and quality 5 can lead to better use of resources.
The suggested investment in evidence-informed policy making could take the form of dedicated funds for the creation of websites of readable, regularly updated summaries of research evidence, with input from both researchers and policy makers. Such an innovative form of stakeholder engagement should be accompanied by robust monitoring and assessment mechanisms to assess its eff ect.
We declare that we have no confl icts of interest. Peter Piot and colleagues 1 neglect to mention the most egregious oversight made by the public health community in dealing with the HIV epidemic: the avoidance of surveillance and contact tracing and the secrecy involved in dealing with potentially infectious cases. Infectious disease control through public health measures has repeatedly shown the effi cacy of making new cases reportable, of identifying and tracing contacts, and of including them in further surveillance and containment eff orts. These basic public health principles have been avoided in HIV over concerns about confi dentiality, which itself has exacerbated the stigma and discrimination that Piot and colleagues admit have been a signifi cant impediment to HIV control. Appropriate measures can protect against these unfortunate outcomes without total secrecy.
Had full implementation of normal public health procedures for control of an emerging infectious disease been followed, such as we saw for severe acute respiratory syndrome (SARS), it is likely that the extent of the AIDS epidemic would have been substantially curtailed. Even at this late date, making the disease reportable and tracing all possible contacts with intensive education of all exposed, along with HIV testing and continued surveillance and needed clinical care, would do much to stem the spread of this epidemic. 
Authors' reply
We agree with Ann Starrs that many important causes of ill health in lowincome and middle-income countries are seriously underfunded, and that "general funding for health as well as specifi cally for AIDS must increase signifi cantly". The momentum created by the global AIDS response has already led to increased funding for health, but clearly not enough. Additionally, effi ciency gains can be made in HIV interventions, and we should do as much as we can to ensure that the synergies between the AIDS response and other health programmes are optimised.
We also support the proposal by Charles Wiysonge and colleagues for more investment in evidenceinformed policy making-the AIDS fi eld has clearly had its share of diffi culties in translating evidence into policies and practices, particularly when it comes to prevention.
Jon Rohde raises the issue of the use of classic measures for communicable disease control such as contact tracing. Whereas such measures have indeed proven eff ective in the control of some outbreaks, the eff ectiveness
